midpage
Sign in to see your projects.
138 A.D.3d 179
N.Y. App. Div.
2016
Read the full case

Background

  • Post-hemorrhoid surgery, Dr. Bute prescribed hydromorphone: up to 8 mg every 3–4 hours PRN; decedent had received ~6 mg in hospital earlier that day.
  • Plaintiff (decedent's wife) filled the prescription at CVS; decedent later took an 8 mg dose and died; autopsy found acute hydromorphone intoxication.
  • Plaintiff sued the prescriber and CVS/pharmacist defendants, alleging prescribing and dispensing negligence (dosage too high for an opioid‑naive patient and failure by pharmacist to verify).
  • CVS moved for summary judgment dismissing claims against it; plaintiff cross‑moved for summary judgment on liability. Supreme Court denied both motions.
  • On appeal, the Second Department considered the scope of a pharmacist's duty when filling physician prescriptions and whether CVS established entitlement to summary judgment.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Scope of pharmacist duty to warn or verify prescription Pharmacist had duty to confirm or warn because 8 mg was contraindicated for opioid‑naive patient Pharmacist's duty is limited to accurately filling prescriptions; physician controls clinical judgment Pharmacist may be liable only if (1) failed to fill prescription exactly as written, or (2) prescription was so clearly contraindicated that a reasonable pharmacist must inquire.
Sufficiency of plaintiff's expert to create triable issue Expert said 8 mg contraindicated for opioid‑naive patient and CVS records showed decedent was opioid‑naive CVS argued expert relied on assumptions not supported by pharmacy records available to pharmacist Expert opinion was based on facts not in the record as known to CVS; insufficient to defeat summary judgment.
Whether CVS filled prescription precisely as directed Plaintiff claimed mislabeling increased max daily dose (64 mg v. 32 mg) CVS showed it filled per physician's directions and any label deviation was not causative Any labeling deviation was not a substantial factor; decedent died after a single 8 mg dose, so no triable issue on causation.
Entitlement to summary judgment Plaintiff sought denial CVS sought dismissal of complaint against them Court granted summary judgment for CVS; order reversed as to cross‑appeal and claims dismissed.

Key Cases Cited

  • Martin v. Hacker, 83 N.Y.2d 1 (N.Y. 1993) (learned intermediary doctrine: manufacturer's duty to warn is satisfied by warning the prescribing physician)
  • N.X. v. Cabrini Med. Ctr., 97 N.Y.2d 247 (N.Y. 2001) (hospital staff need not second‑guess physician unless orders are so clearly contraindicated as to require inquiry)
  • Toth v. Community Hosp. at Glen Cove, 22 N.Y.2d 255 (N.Y. 1968) (staff following physician orders protected unless orders are so clearly contraindicated that inquiry is required)
  • Burton v. Sciano, 110 A.D.3d 1435 (App. Div. 2013) (no duty found where complaint lacked allegation that pharmacy knew or should have known prescription was contraindicated)
  • Brumaghim v. Eckel, 94 A.D.3d 1391 (App. Div. 2012) (similar principle: pharmacist not liable absent knowledge of contraindication)
  • Eberle v. Hughes, 77 A.D.3d 1398 (App. Div. 2010) (pharmacist may breach duty when patient history and warnings put pharmacist on notice)
  • Hand v. Krakowski, 89 A.D.2d 650 (App. Div. 1982) (pharmacist issued opiates contrary to known patient history of alcoholism; duty to avoid known contraindications)
Read the full case

Case Details

Case Name: Abrams v. Bute
Court Name: Appellate Division of the Supreme Court of the State of New York
Date Published: Mar 9, 2016
Citations: 138 A.D.3d 179; 27 N.Y.S.3d 58; 2016 NY Slip Op 01627; 2013-04173
Docket Number: 2013-04173
Court Abbreviation: N.Y. App. Div.
Log In